Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome

Jeļena Eglīte; Oksana Koļesova; Aleksandrs Koļesovs; Vladislavs Jasinskis; Elvīra Hagina; Inga Januškeviča; Gunta Stūre; Ksenija Kramiča; Baiba Rozentāle; Jeļena Storoženko; Ludmila Vīksna

Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome

Translated title of the contribution: Pēkšņas nāves riska prognozēšanas paņēmiens slimniekiem ar HIV un tuberkulozes (HIV/TB) duālo koinfekciju, tai skaitā IRIS sindroma gadījumā

Jeļena Eglīte (Inventor), Oksana Koļesova (Inventor), Aleksandrs Koļesovs (Inventor), Vladislavs Jasinskis (Inventor), Elvīra Hagina (Inventor), Inga Januškeviča (Inventor), Gunta Stūre (Inventor), Ksenija Kramiča (Inventor), Baiba Rozentāle (Inventor), Jeļena Storoženko (Inventor), Ludmila Vīksna (Inventor)

Rīga Stradiņš University

Research output: Intellectual property › Patent

Abstract

Invention relates to medicine, namely, to genetic tests for prognosing a risk of sudden death in patients with HIV and tuberculosis co‑infection, including those
with IRIS syndrome. Risk markers used in a method are interleukin IL‑18 and genotype of locus HLA‑DQB1 class II genes.

Translated title of the contribution	Pēkšņas nāves riska prognozēšanas paņēmiens slimniekiem ar HIV un tuberkulozes (HIV/TB) duālo koinfekciju, tai skaitā IRIS sindroma gadījumā
Original language	Latvian
Patent number	15 270
IPC	C12Q1/68
Priority date	5/07/17
Filing date	5/07/17
Publication status	Published - 20 May 2018

Keywords*

risk of sudden death
HIV and tuberculosis co‑infection

Field of Science*

3.2 Clinical medicine

Patent expiration date

01.02.2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://databases.lrpv.gov.lv/databases/lv/patent/details/p-17-46/

Cite this

Eglīte, J., Koļesova, O., Koļesovs, A., Jasinskis, V., Hagina, E., Januškeviča, I., Stūre, G., Kramiča, K., Rozentāle, B., Storoženko, J., & Vīksna, L. (2018). Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome. (Patent No. 15 270). Patent Office of the Republic of Latvia. http://databases.lrpv.gov.lv/databases/lv/patent/details/p-17-46/

@misc{9feacf2ba36d42038905091d48e78980,

title = "Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome",

abstract = "Invention relates to medicine, namely, to genetic tests for prognosing a risk of sudden death in patients with HIV and tuberculosis co‑infection, including those with IRIS syndrome. Risk markers used in a method are interleukin IL‑18 and genotype of locus HLA‑DQB1 class II genes.",

keywords = "risk of sudden death, HIV and tuberculosis co‑infection",

author = "Jeļena Eglīte and Oksana Koļesova and Aleksandrs Koļesovs and Vladislavs Jasinskis and Elvīra Hagina and Inga Janu{\v s}kevi{\v c}a and Gunta Stūre and Ksenija Krami{\v c}a and Baiba Rozentāle and Jeļena Storo{\v z}enko and Ludmila Vīksna",

year = "2018",

month = may,

day = "20",

language = "Latvian",

publisher = "Patent Office of the Republic of Latvia",

type = "Patent",

note = "15 270; C12Q1/68",

}

Eglīte, J, Koļesova, O , Koļesovs, A, Jasinskis, V, Hagina, E, Januškeviča, I, Stūre, G, Kramiča, K, Rozentāle, B , Storoženko, J & Vīksna, L May. 20 2018, Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome, Patent No. 15 270. <http://databases.lrpv.gov.lv/databases/lv/patent/details/p-17-46/>

TY - PAT

T1 - Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome

AU - Eglīte, Jeļena

AU - Koļesova, Oksana

AU - Koļesovs, Aleksandrs

AU - Jasinskis, Vladislavs

AU - Hagina, Elvīra

AU - Januškeviča, Inga

AU - Stūre, Gunta

AU - Kramiča, Ksenija

AU - Rozentāle, Baiba

AU - Storoženko, Jeļena

AU - Vīksna, Ludmila

PY - 2018/5/20

Y1 - 2018/5/20

N2 - Invention relates to medicine, namely, to genetic tests for prognosing a risk of sudden death in patients with HIV and tuberculosis co‑infection, including those with IRIS syndrome. Risk markers used in a method are interleukin IL‑18 and genotype of locus HLA‑DQB1 class II genes.

AB - Invention relates to medicine, namely, to genetic tests for prognosing a risk of sudden death in patients with HIV and tuberculosis co‑infection, including those with IRIS syndrome. Risk markers used in a method are interleukin IL‑18 and genotype of locus HLA‑DQB1 class II genes.

KW - risk of sudden death

KW - HIV and tuberculosis co‑infection

UR - https://www.lrpv.gov.lv/sites/lrpv/files/media_file/201710201.pdf

M3 - Patent

M1 - 15 270

Y2 - 2017/07/05

PB - Patent Office of the Republic of Latvia

ER -

Method of prognosis of risk of sudden death in patients with HIV and tuberculosis Co-infection (HIV/TB) including case of IRIS syndrome

Abstract

Keywords*

Field of Science*

Patent expiration date

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this